Team develops new way to fight HIV transmission

April 16, 2018, University of Waterloo
Scientists at the University of Waterloo have developed a new tool to protect women from HIV infection. Credit: University of Waterloo

Scientists at the University of Waterloo have developed a new tool to protect women from HIV infection.

The tool, a vaginal implant, decreases the number of cells that the HIV virus can target in a woman's . Unlike conventional methods of HIV prevention, such as condoms or anti-HIV drugs, the implant takes advantage of some people's natural immunity to the virus.

HIV infects the body by corrupting T cells that are mobilized by the immune system when the virus enters a person's body. When the T cells stay resting and do not attempt to fight the virus they are not infected and the HIV virus is not transmitted between people. When the T cells stay resting, it's referred to as being immune quiescent.

"We know that some drugs taken orally never make it to the vaginal tract, so this implant could provide a more reliable way to encourage T cells not to respond to infection and therefore more reliably and cheaply prevent transmission," said Emmanuel Ho, a professor in the School of Pharmacy at Waterloo. "What we don't know yet is if this can be a stand-alone option for preventing HIV transmission or if it might be best used in conjunction with other prevention strategies. We aim to answer these questions with future research."

University of Waterloo develops new way to fight HIV transmission
Professor Emmanuel Ho, a professor of the School of Pharmacy at Waterloo displays new HIV prevention implant for women. Credit: University of Waterloo

Ho's implant was inspired by previous research involving sex workers in Kenya. In Kenya, Ho and research partner Keith Fowke of the University of Manitoba, observed that many of these women who had sex with HIV positive clients but did not contract the . They later found the women possessed T that were naturally immune quiescent.

"Observing this, we asked ourselves if it was possible to pharmacologically induce immune quiescence with medication that was better assured of reaching the point of infection," said Ho. "By delivering the medication exactly where it's needed, we hoped to increase the chances of inducing immune quiescence."

The implant is composed of a hollow tube and two pliable arms to hold it in place. It contains hydroxychloroquine (HCQ) which is disseminated slowly through the porous material of the tube and absorbed by the walls of the vaginal tract.

The implants were tested in an animal model and the team observed a significant reduction in T cell activation, meaning that the vaginal tract was demonstrating an immune quiescent state.

The article recently appeared in the Journal of Controlled Release.

Explore further: Infection site affects how a virus spreads through the body

Related Stories

Infection site affects how a virus spreads through the body

February 20, 2018
A person is more likely to get infected by HIV through anal intercourse than vaginal, but no one knows quite why. A new study by scientists at the Gladstone Institutes shows that infection sites could affect the immune system's ...

Zika monkey study suggests worse fetal effects for vaginal versus mosquito transmission

August 24, 2017
Rhesus macaques that were vaginally infected with Zika virus showed higher prevalence of Zika in the reproductive tract than previously seen in macaques that received skin injections of the virus. The findings, published ...

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

Study sheds new light on why the effectiveness of a popular HIV prevention method varies in women

March 1, 2018
Why do some women get HIV infection, even though they are using tenofovir gel for prophylaxis?

Zika virus may persist in the vagina days after infection

August 25, 2016
The Zika virus reproduces in the vaginal tissue of pregnant mice several days after infection, according to a study by Yale researchers. From the genitals, the virus spreads and infects the fetal brain, impairing fetal development. ...

Researchers discover new details about HIV-1 entry and infection

February 15, 2007
The primary targets of HIV-1 infection in the human vagina have been definitively identified in a new study published in the February 2007 issue of the journal Immunity, published by Cell Press. The findings are likely to ...

Recommended for you

Details of HIV-1 structure open door for potential therapies

August 9, 2018
New research provides details of how the structure of the HIV-1 virus is assembled, findings that offer potential new targets for treatment.

Researchers uncover potential new drug targets in the fight against HIV

August 7, 2018
Johns Hopkins scientists report they have identified two potential new drug targets for the treatment of HIV. The finding is from results of a small, preliminary study of 19 people infected with both HIV—the virus that ...

Naltrexone helps HIV positive individuals reduce heavy alcohol use

August 7, 2018
Extended-release naltrexone—an injection that decreases heavy drinking in the general population when taken in conjunction with counseling—appears to help HIV-positive individuals reduce their number of heavy drinking ...

EU door opens for generic version of AIDS medicine Truvada

July 26, 2018
Patient associations on Thursday lauded an EU decision to allow the sale of generic versions of Truvada, an anti-retroviral medicine used by those diagnosed HIV-positive, the virus causing AIDS.

First randomised trial of 'kick and kill' approach to HIV cure leaves puzzles to be solved

July 24, 2018
Researchers have reported the results of the first randomised clinical trial to test a novel strategy involving waking up and then killing the 'sleeping' HIV that is hiding in the body using an experimental approach known ...

Scientists report setbacks in quest for AIDS cure

July 24, 2018
Scientists reported setbacks Tuesday in the quest for an AIDS cure, and highlighted concerns about inconclusive evidence linking a promising new HIV drug to birth defects.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.